SNSS: Summary for Sunesis Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:27am EST - Canadian Markets open in 3 hours and 3 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Sunesis Pharmaceuticals Inc. (SNSS)

On Feb 9: 0.8197 USD 0.00 (0.00%)

MORE ON SNSS

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Sunesis Pharmaceuticals, Inc. (NCM:SNSS) Delayed quote data

Last Trade:	0.8197 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.8197
Open:	N/A
Bid:	0.78 x 900
Ask:	1.05 x 200
1y Target Est:	1.75

Day's Range:	N/A - N/A
52wk Range:	0.05 - 2.43
Volume:	0
Avg Vol (3m):	6,371,310
Market Cap:	28.21M
P/E (ttm):	N/A
EPS (ttm):	-2.019
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add SNSS to Portfolio

Download Data

HEADLINES

•	Sunesis Grants Carmot Therapeutics License to Its Drug Discovery Technology
	Marketwire (Mon, Feb 8)

•	Sunesis Completes Enrollment of Voreloxin Phase 1b/2 Combination Trial in Acute Myeloid Leukemia
	Marketwire (Thu, Jan 21)

•	SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of
	EDGAR Online (Thu, Jan 21)

•	Biotech Stocks: Drug stocks climb; Cerus, Osteotech gain
	at MarketWatch (Thu, Jan 14)

•	Biotech Stocks: Drug stocks sluggish; Sunesis, Cerus soar
	at MarketWatch (Thu, Jan 14)

•	Sunesis Announces Publication of Nonclinical Voreloxin Data in Leukemias
	Marketwire (Thu, Jan 14)

•	Sunesis, Taser: Midday Volume Plays
	at TheStreet.com (Wed, Jan 6)

•	Fear & Greed in 2010 and 3 PowerRated Stocks
	TradingMarkets.com (Mon, Jan 4)

•	Sunesis registers for stock sale of up to $50M
	at bizjournals.com (Mon, Dec 28)

•	Flotek, Sunrise: Midday Volume Plays
	at TheStreet.com (Mon, Dec 28)

More Headlines for SNSS...

ANALYST

EPS Est (next year) (Dec-09) :	-1.95
EPS Est (in 2 years) (Dec-10) :	-0.29
Avg Rec (current)*:	1.7
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for hematologic and solid tumor cancers.

Full Company Profile

Add to Portfolio

Email to a Friend

•